Overview

Combination Chemotherapy in Treating Patients With Advanced Cancer

Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining 3-AP with cisplatin in treating patients who have advanced cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Vion Pharmaceuticals
Treatments:
Cisplatin